Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILE THERAPEUTICS, INC.

(AGRX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
0.8871(c) 0.86(c) 0.8606(c) 0.8494(c) 0.8064(c) Last
19 277 639 5 855 530 1 789 083 1 563 987 2 991 744 Volume
+16.72% -3.05% +0.07% -1.30% -5.06% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 4,78 M - -
Net income 2021 -71,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,06x
Yield 2021 -
Sales 2022 26,1 M - -
Net income 2022 -67,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,36x
Yield 2022 -
Capitalization 96,5 M 96,5 M -
Capi. / Sales 2021 20,2x
Capi. / Sales 2022 3,70x
Nbr of Employees 28
Free-Float 78,0%
More Financials
Company
Agile Therapeutics, Inc. is a women’s healthcare company. The Company’s approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla uses its transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability, which may help support compliance. Its product... 
More about the company
Ratings of Agile Therapeutics, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about AGILE THERAPEUTICS, INC.
10/22AGILE THERAPEUTICS : to Report Third Quarter 2021 Financial Results and Provide Business U..
AQ
10/15AGILE THERAPEUTICS INC : Regulation FD Disclosure (form 8-K)
AQ
10/12AGILE THERAPEUTICS : Applauds Congressional Chairs' Letter to Biden Administration Request..
AQ
10/08AGILE THERAPEUTICS : Appoints Josephine Torrente to its Board of Directors - Form 8-K
PU
10/08AGILE THERAPEUTICS INC : Change in Directors or Principal Officers, Regulation FD Disclosu..
AQ
10/08AFTER HOURS WATCH LIST SCORECARD : Vxrt, agrx, allo
MT
10/08AGILE THERAPEUTICS : Appoints Josephine Torrente to its Board of Directors
AQ
10/08Agile Therapeutics Appoints Josephine Torrente to Its Board of Directors
CI
10/08Top Midday Decliners
MT
10/08AGILE THERAPEUTICS : Prices Public Offering of Shares and Warrants to Raise $22.7 Million
MT
10/08AGILE THERAPEUTICS : Announces Pricing of $22,666,650 Underwritten Public Offering of Comm..
GL
10/08Top Premarket Decliners
MT
10/07MT NEWSWIRES AFTER HOURS WATCH LIST : Vxrt, agrx, allo
MT
10/07AGILE THERAPEUTICS : Plans Common Stock Offering; Shares Plunge After-Hours
MT
10/07Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and ..
GL
More news
News in other languages on AGILE THERAPEUTICS, INC.
10/07Agile Therapeutics propose une offre d'actions ordinaires ; les actions plongent après ..
2017Wall Street marque le pas avant Noël, Nike pèse
More news
Analyst Recommendations on AGILE THERAPEUTICS, INC.
More recommendations
Chart AGILE THERAPEUTICS, INC.
Duration : Period :
Agile Therapeutics, Inc. Technical Analysis Chart | AGRX | US00847L1008 | MarketScreener
Technical analysis trends AGILE THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,81 $
Average target price 4,13 $
Spread / Average Target 412%
EPS Revisions
Managers and Directors
Alfred F. Altomari Chairman & Chief Executive Officer
Dennis P. Reilly Chief Financial Officer & Senior Vice President
Charles S. Grass Senior Director-Finance
Paul Korner Chief Medical Officer
Tristen Herrstrom Senior VP-Human Resources & Administration
Sector and Competitors
1st jan.Capi. (M$)
AGILE THERAPEUTICS, INC.-71.90%96
GILEAD SCIENCES, INC.15.41%84 306
BIONTECH SE241.44%67 225
WUXI APPTEC CO., LTD.24.51%64 578
REGENERON PHARMACEUTICALS18.47%59 507
VERTEX PHARMACEUTICALS-22.35%47 610